Key Account Management Excellence in Pharma & Medtech is designed to help life sciences practitioners develop and execute innovative and effective key account management (KAM) strategies and capabilities. Pharmaceutical and medtech companies are increasingly pursuing KAM in response to the rapid rise of large, sophisticated and complex healthcare provider and payer systems and groups. Those that invest the time to get KAM right will protect their business and grow with these rising customers.

This book is groundbreaking in both its scope and its tailoring of leading KAM practices specifically for life sciences. The central theme is that "key account management is an organization-wide business strategy, not just a role or a sales-specific initiative." KAM is a strategy focused on providing unique offerings and value through an orchestrated, cross-functional, go-to-market model designed specifically to address the needs and engagement preferences of a unique segment of customers. The insights and practices shared in this book are designed to be a valuable reference at every stage of the KAM journey.

The book has been designed to facilitate a common language and deep understanding of KAM issues and leading practices organization-wide-particularly for life sciences leaders, account managers and cross-functional team members responsible for building, transforming and supporting their organization's KAM strategies and capabilities.

About the Author

Mike Moorman is a Principal at ZS and leads the firm's key account management practice. Mike founded ZS's B2B commercial strategy and transformation practice and is a recognized expert in his field. He has worked globally and with more than 50 B2B organizations across 12 industries. Mike serves on the Board of Directors and the Research Advisory Board for the Strategic Account Management Association, and is an Adjunct Lecturer on Sales Strategy at Northwestern's Kellogg Executive Program. Mike has authored more than 60 publications and has been cited in leading publications including Harvard Business Review, Financial Times, The Wall Street Journal, IndustryWeek, USA Today and Selling Power.

Reviews

"A truly holistic approach to KAM-one that the pharma and medtech industries desperately need."

Mitch Payne, Global Head, Value and Access Excellence at Novartis Oncology

"Pharma and medtech finally get their own KAM/SAM 'bible' with unique and relevant insights."

Dino Bertani, Executive Director, International Strategic Account Management at AbbVie

"A 'KAM blueprint must' for life sciences leaders at the critical juncture of shaping versus reacting to their future."

Barbara Ruhland, Head of Strategic Accounts & Channel Management, US Radiology at Bayer

"This thought leadership has been an invaluable playbook that I have read and reread to guide our progress."

Todd Burgess, Global Key Account Manager Capabilities Leader at Merck

"A terrific resource for SAM leaders in any industry-one I wish I had during my time at Schneider Electric."

Harvey Dunham, Managing Director, Strategy and Marketing at Strategic Account Management Association

"One of the most comprehensive books to date on the topic of SAM... it uniquely addresses SAM in life sciences... I believe this book should be a 'must read' for any life sciences leader, account manager or cross-functional team member responsible for supporting SAM strategies and capabilities."

Denise Freier, President and CEO, Strategic Account Management Association

Book Information
ISBN 9781032128580
Author Mike Moorman
Format Paperback
Page Count 216
Imprint Routledge
Publisher Taylor & Francis Ltd
Weight(grams) 400g